The Guardian Australia
·general
·2 hours ago
Trump signs order to expedite psychedelics research, boosting multibillion-dollar market
Donald Trump signed an executive order on April 19 to expedite research into psychedelics, including ibogaine, likely boosting the multibillion-dollar market. The FDA will fast-track reviews for psilocybin and MDMA applications, reflecting a significant shift in attitudes towards these substances. However, concerns linger over access and potential conflicts with the DEA regarding the 'right to try' legislation.
Summary by Glance · The Guardian Australia
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI